NASW-LA Chapter-Using MI and SBIRT to Support Clients in COV

234100_012: "NASW-LA Chapter Sponsored Workshop" FREE for Members and Non-Members. Topic:  Using Motivational Interviewing (MI) and Screening, Brief Intervention and Referral To Treatment (SBIRT) To Support Clients In Covid-19 Vaccine Decision Making.  This interactive training will introduce motivational interviewing (MI) and Screening, Brief Intervention and Referral to Treatment (SBIRT), and how these evidence-based modalities can be effectively deployed to help guide collaborative conversations with clients about COVID-19 vaccine decision-making.  MI is a collaborative conversation approach that develops and strengthens a client’s motivation for and commitment to change around health-related behavior(s). The MI framework recognizes the client as the expert in their own lived experience. Research on MI has demonstrated its benefits with marginalized populations who have not necessarily received equitable and affirming experiences in care and health settings. Topics will include the MI spirit and MI core skills to help clients resolve ambivalence towards positive change. The training will also introduce SBIRT, a five-step model for working with clients with substance use disorders which can be adapted for use in supporting vaccine decision making. The training is provided through Connect to End COVID-19, an initiative of NASW, the NASW Foundation and the University of Texas at Austin Steve Hicks School of Social Work, with funding from the Centers for Disease Control and Prevention. Presented by Lloyd Berg, Ph.D. and Leslie Sirrianni, LCSW.  5.0 General hours.  Pre-registration is required to be awarded CEU credit.

For more information on this effort, go to

Note:  Once you are registered, you will receive via email a survey that is required for your participation by the CDC.  The training will not be recorded; participants must attend all day to receive CEUs.  

9/29/2022 9:00 AM - 3:00 PM


Tuesday, 04 October 2022

10/4/2022 3:00 PM - 10/19/2022 11:59 PM
10/4/2022 3:00 PM

Sign In